"COVID-19: What Pharmacists Need to Know" offers a multi-module CE webinar curriculum program that delivers current, credible information.
The curriculum features webinars on key issues related to the changing landscape of pharmacy practice in light of COVID-19, each with a different expert faculty presenter:
Webinar 1: "COVID-19 Basics and Effect on Pharmacy Practice," Rupal Mansukhani, Pharm.D., FAPhA, CTTS, on-demand webinar available here.
Webinar 2: "Existing and Investigational Pharmacotherapy for COVID-19," Jason C. Gallagher, Pharm.D., FCCP, FIDP, FIDSA, BCPS, on May 31, at 12:00 p.m. EST.
Webinar 3: "COVID-19: Industry's Response and Caring for Patients on the Front Line," Mary Barna Bridgeman, Pharm.D., BCPS, BCGP, on June 7, at 12:00 p.m. EST.
Webinar 4: "Psychosocial Effects and Quality of Life Impact of COVID-19," Mona K. Patel, Pharm.D., FCCM, BCCCP, on June 14, at 12:00 p.m. EST.
Webinar 5: "Update on COVID-19 Clinical Data and Impact on Reimbursement or Patient Access," Kelly E. Pillinger, Pharm.D., BCPS, BCIDP, on June 28, at 12:00 p.m. EST.
Completing these CE webinars will equip pharmacists with the most up-to-date data available on virology, emerging therapies and vaccines and patient management, as well as mental health, financial and quality of life burdens of COVID-19 on patients and health care personnel. Participants who complete all activities in this series will receive a certificate of completion.
Each activity is accredited by the Accreditation Council for Pharmacy Education and is approved for 0.75 contact hour (0.075 CEU).
This resource center is supported by an educational grant from Pfizer Inc.
Pharmacy Times Continuing Education is in continuing education for retail, health system, managed care and specialty pharmacists. PTCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
PTCE's print, online and live CPE activities are designed to improve the knowledge, competence and skills of pharmacists to better prepare them to provide the highest quality of pharmacy care to the patients they serve and the physicians they assist as part of a multidisciplinary treatment and management team.
PTCE is a brand of MJH Life Sciences, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
FDA lifts pause on Valneva's chikungunya vaccine IXCHIQ for elderly, updates prescribing information
Anixa Biosciences begins US FDA approved IND transfer to support Phase 2 breast cancer vaccine trial
Pfizer and BioNTech receive EU regulatory backing for LP.8.1-adapted COVID-19 vaccine
Sanofi to acquire Vicebio for USD1.15bn to strengthen respiratory vaccine pipeline
Bavarian Nordic chikungunya vaccine enters Health Canada review process
SK bioscience submits IND for Phase 1/2 clinical trial of new influenza vaccine candidate
GC Biopharma secures Vietnamese approval for varicella vaccine BARYCELA
GSK announces submission of RSV vaccine Arexvy for FDA review
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Centivax raises USD45m to commercialise universal flu vaccine
CyanVac's nasal COVID vaccine shows promise in phase 1 trial
hVIVO supports Cidara Therapeutics' positive Phase 2b influenza study results
Valneva signs exclusive German vaccine distribution deal with CSL Seqirus